Our 7th annual
Biosimilars Europe conference returns to London this September!
The development of the
Biosimilars market is growing exponentially with the industry forecast to be worth $25 billion by 2020. With the regulatory landscape evolving rapidly, it is important to understand the developments in the
biosimilar guideline framework and the cohesion in legislation between Europe and the US.
With Europe leading the way in the field of
Biosimilar development, it is important to get to grips with all areas in the product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments. Every angle should be considered and taken account for through the development process and with the EU the most advanced market for
biosimilars, accounting for 80% of global spending on these molecules, the learning curve for
biosimilars is essentially still building and there are hurdles to overcome.
Benefits of Attending
- HEAR the latest on the evolving regulatory biosimilar landscape and review the guidelines
- GAIN understanding on the barriers being faced for market access and commercialisation of products through case-study led presentations
- FOCUS on the global market developments with case studies on Emerging Markets of biosimilars and assessing the trends we are currently seeing
- ASSESS and review in-depth protein characterisation and analytical comparability to efficiently and effectively collect data
Plus Two Interactive Half-Day Pre-Conference Workshops | Wednesday 28th September 2016
Biosimilars: Maximisation of IP regulatory rightsWorkshop Leaders: Marie Manley, Partner and Head of the Regulatory Department, Bristows LLP and Libby Amos, Associate, Regulatory Department, Bristows LLP
8.30am - 12.30pm
How is the payer environment for biosimilars evolving?Workshop Leader: Dr Ad Rietveld, Director, RJW & partners Ltd
1.30pm - 5.30pm
Speakers
- Ad Rietveld, Ad Rietveld, RJW & partners Ltd
- Alan Sheppard, Principal, Global generics and biosimilars, IMS Health
- Alok Sharma, Principal Scientist & Head Analytical Development , Lupin Limited
- Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety
- Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
- Dirk Kreder, Founder and CEO, Anteris Medical GmbH
- Dominic Adair, Partner, Bristows LLC
- Duncan Emerton, Senior Director, Syndicated Insights & Analysis, FirstWord
- Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co. Ltd
- Jim Nelson, Senior Shareholder and Principal, Schwegman Lundberg Woessner
- Joan O'Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority
- Laura Perry, Director of Scientific Affairs, Cell Line Development, Abzena
- Luis Borlido, Lab Head Characterization, Sandoz International GmBH
- Niraj Chhaya, Senior Risk Management Physician, Boehringer Ingelheim GmbH
- Steinar Madsen, Medical Director, Norwegian Medicines Agency
- Virginia Acha, Executive Director and Research, Medical and Innovation, ABPI
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side o f the page.
Venue
Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK
Who should attend
Job titles include but are not restricted to:
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, from the following roles:
- Biopharmaceuticals/ Biotherapeutics
- Follow on Biologics/Follow on Proteins/Biosimilars
- Biologics/Biotechnology/ Biogenerics
- Legal and Regulatory Affairs
- Intellectual Property
- Health Economics
- Pricing and Reimbursement
- Clinical Immunology
- Process Control and Analytical Technologies
- Analytical Characterisation
- Regulatory Compliance
- Pharmacovigilance
- Drug Safety & Risk Management
- Quality Affairs/ Quality Control
- New Product Development
- Process Science
- Portfolio Management
- Research & Development
- Business Development
- Business Operations
- Scientific Affairs
- Commercial Affairs and Strategic Planning
- Legislation and Policy Advice
Venue
Holiday Inn Kensington Forum97 Cromwell Road
London, United Kingdom
